Font Size: a A A
Keyword [Anti-hiv]
Result: 161 - 180 | Page: 9 of 10
161. Transport phenomena in anti-HIV microbicide delivery vehicles
162. Design and evaluation of nucleoside derivatives for targeted drug delivery and therapeutic applications
163. Mechanistic Models of Anti-HIV Microbicide Drug Delivery
164. Investigation of the Anti-HIV Effects and Underlying Mechanisms of Chinese Medicines
165. DDB and betulinic acid-derivatives as potent chemosensitizing, chemopreventive, and anti-HIV agents
166. An examination of the Index of Readiness as a predictor of adherence and an adherence intervention in HIV+ males who repeatedly failed anti-HIV treatment regimens (Immune deficiency)
167. Synthesis and anti-HIV-1 activities of novel N-O bond incorporataed nucleosides
168. Bolivian medicinal herbs as source of leads for anti -tumor and anti -HIV drugs
169. 1. Development of a novel ELISA for the testing of glycobioconjugates as anti-HIV agents. 2. Synthesis of potential inhibitors of the HIV entry mechanism. 3. Probing the secondary structural characteristics of oligosaccharides utilizing circular dichroi
170. Synthesis of potential anti-HIV agents and prodrugs: Part I synthesis of L-3'-hydroxymethylnucleosides. Part II synthesis and pharmacokinetics of 3'-azido-2',3'-dideoxyuridine (AZDU) as prodrugs
171. Design, synthesis and biological evaluation of betulin analogs as anti-HIV agents (Immune deficiency)
172. Modeling the impacts of an anti-HIV drug treatment program on the HIV epidemic (Immune deficiency)
173. IgE anti-HIV-1 in serum of HIV-1 infected children inhibits HIV-1 production in vitro and IgE mediates cytotoxicity against lymphoma cells expressing HIV-1 and peripheral blood mononuclear cells from an HIV-1 seropositive patien
174. Bolivia-Kallawayan medicinal plants as leads to anti-HIV, anti-tumor and other potential drugs
175. In vitro and in vivo catabolism of the anti-HIV 2',3'-dideoxynucleoside, 3'-azido-3'-deoxythymidine (AZT)
176. Study Of Mechanisms For Development Of Anti-HIV-1 Broadly Neutralizing Antibodies In SHIV-infected Chinese Rhesus Macaques
177. The Effect And Mechanism Of Anti-HIV Treatment Efavirenz On Lipid Metabolism And Ulcerative Colitis
178. Screening Of Anti-HIV-1 Inhibitors Targeting Vif-CBF? Interaction
179. Structural Modification And Hydroxyhalogenation Of Chromen-2-ones With Anti-HIV Activity
180. Research On Anti-HIV Target And Drug Resistance Of Indole Derivative RJQ-1
  <<First  <Prev  Next>  Last>>  Jump to